Tandem Diabetes Care (NASDAQ: TNDM) stock exploded higher after reporting a sales beat Thursday evening. Analysts forecast the maker of t:slim X2 insulin pumps would lose $0.76 per share on sales of $174 million in 2024's first quarter. Tandem did lose money but only $0.65 per share -- and beat soundly ...
motleyfoolusx:tndm
About a half-billion adults in the world have diabetes. This chronic health condition causes severe hardships to patients and contributes substantially to healthcare costs. It's no wonder that many companies continue developing innovative products to help diabetes patients manage the disease. One of ...
motleyfoolusx:tndm
